Yitshak “Itsik” Francis
Dr. Yitshak Francis is director of business development at Ariel Scientific Innovations, Ariel University’s technology transfer company, and is Ariel’s board observer. Dr. Francis received his biology degree from the Technion in Israel and his Ph.D. in medical molecular biology from University College, London. He conducted his postdoctoral training at Columbia University, where he worked on several drug development projects. He was a co-founder and CEO for Citta Pharmaceuticals, a Columbia biotechnology spin-off that develops Alzheimer’s therapies.